Could cause temporary or reversible harm; serious harm is unlikely.
Failed Impurities/Degradation Specifications.
| Brand name | HYDROCORTISONE SODIUM SUCCINATE |
| Generic name | HYDROCORTISONE SODIUM SUCCINATE |
| Active ingredient(s) | HYDROCORTISONE SODIUM SUCCINATE |
| Distributed by / for | Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534 |
| NDC | 70710-1907-1 |
| Full product label | Hydrocortisone Sodium Succinate for Injection, USP 100 mg/vial, 1 Vial, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Vadodara - 391510 India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1907-1. |
| Recalling firm | Zydus Pharmaceuticals (USA) Inc |
| Distribution | Nationwide within the United States |
| Quantity | 70776 vials |
| Recall initiated | 2026-10-01 |
| Report date | 2026-10-21 |
| Recall completed | — |
| Recall number | D-0039-2027 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Pennington NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗